News
This effort aligns with the objectives of Saudi Vision 2030, which aims to address the clinical and economic challenges posed ...
Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least ...
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Novo Nordisk A/S (NYSE:NVO) is one of the stocks Jim Cramer recently discussed. Novo Nordisk A/S (NYSE:NVO ...
A significant advancement in weight management has arrived for Singaporeans. Danish pharma Novo Nordisk has announced the ...
12h
Bangkok Post on MSNNovo Nordisk Brings Cities for Better Health to BangkokFollowing a visit to Copenhagen, Denmark, to collaborate on enhancing urban health, the Bangkok Metropolitan Administration (BMA) and Novo Nordisk will launch the Cities for Better Health (CBH) ...
15h
Arabian Post on MSNSingapore Welcomes Wegovy® As A New Prescription Weight‐Loss OptionA once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a ...
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the stocks Jim Cramer recently discussed. Hims & Hers ...
16h
Zacks.com on MSNBull of the Day: Hims & Hers Health (HIMS)Hims & Hers Health (HIMS) is quickly becoming one of the most compelling stories in the market as an emerging powerhouse in the direct-to-consumer healthcare space. The stock has posted outsized gains ...
A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was approved for weight loss in March 2025 with a doctor’s prescription. The drug ...
Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday ...
Nandita Vijayasimha, Bengaluru Saturday, July 12, 2025, 08:00 Hrs [IST] ...
People in Business Absci recently announced the appointment of veteran biopharmaceutical executive Mary Szela to its board of directors. With decades of research and development and commercial lea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results